Skip to main content
Clinical Trials/NCT05752747
NCT05752747
Completed
N/A

The Effect of Shotblocker and Cold Massage on Pain, Crying Time and Physiological Parameters During Vaccine Injection in Babies

T.C. ORDU ÜNİVERSİTESİ1 site in 1 country108 target enrollmentNovember 22, 2022
ConditionsVaccinePain

Overview

Phase
N/A
Intervention
Not specified
Conditions
Vaccine
Sponsor
T.C. ORDU ÜNİVERSİTESİ
Enrollment
108
Locations
1
Primary Endpoint
SpO2
Status
Completed
Last Updated
last year

Overview

Brief Summary

The aim of this study is to determine the effect of ShotBlocker© and cold massage on pain, crying time and physiological parameters during DaBT-IPA-Hib vaccine administration in 2-6 months old babies.

Detailed Description

The aim of this study is to determine the effect of ShotBlocker© and cold massage on pain, crying time and physiological parameters during DaBT-IPA-Hib vaccine administration in 2-6 months old babies.This study was planned as randomized controlled experimental single-blind. The population of the research will be 2-6 months old babies who come to Giresun Güce District State Hospital Family Health Center to receive DaBT-IPA-Hib vaccine between the dates of the research. The sample of the study will consist of infants who met the case selection criteria, accepted to participate in the study and were vaccinated between the specified dates. As a result of the power analysis, it was determined that a total of 99 infants, 33 of whom were to be applied cold massage, 33 to be administered ShotBlocker©, and 33 to the control group, who were 2-6 months old to be administered DaBT-IPA-Hib vaccine, met the case selection criteria and agreed to participate in the study. Considering the possibility of case losses, a total of 108 babies, 36 in each group, are planned to be included in the study.

Registry
clinicaltrials.gov
Start Date
November 22, 2022
End Date
June 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
T.C. ORDU ÜNİVERSİTESİ
Responsible Party
Principal Investigator
Principal Investigator

Dilek Kucuk Alemdar

Associate professor

T.C. ORDU ÜNİVERSİTESİ

Eligibility Criteria

Inclusion Criteria

  • The baby is 2-6 months old,
  • DaBT- IPA- Hib vaccine will be administered,
  • The baby does not have a chronic disease,
  • Parents must be at least primary school graduate,
  • Parent's willingness to participate in the study.

Exclusion Criteria

  • Having a congenital or neurological health problem,
  • Have taken an analgesic drug in the last 4 hours,
  • Babies with a body temperature above 37.5 will not be included in the study.

Outcomes

Primary Outcomes

SpO2

Time Frame: 1 minute after the procedure

Physiological parameters

Pulse

Time Frame: 1 minute after the procedure

Physiological parameters

FLACC Pain Scale (Face, Legs, Activity, Cry, Consolability Pain Scale)

Time Frame: 1 minute after the procedure

The FLACC scale was first developed by Merkel et al.in 1997. In the research, it will be used to evaluate the pain levels of infants in the experimental and control groups before, during and after vaccination. The five behaviors ("face", "legs", "activity", "crying" and "consolation") evaluated on this scale are considered indicators of pain that can be detected and graded by an observer. Descriptors for each item are accepted as indicators of children's painful behavior. Each item is scored from 0 to two, resulting in a pain intensity score ranging from 0 to 10. And descriptors associated with each score level represent pain intensity.

Body temperature

Time Frame: 1 minute after the procedure

Physiological parameters

crying

Time Frame: 1 minute after the procedure

crying time will be measured and noted.

Study Sites (1)

Loading locations...

Similar Trials